Pages that link to "Q36318021"

The following pages link to Biomarker discovery in urogenital cancer (Q36318021):

Displaying 13 items.

• The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice (Q21562496) (← links)
• A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma. (Q34111701) (← links)
• A standardized and reproducible urine preparation protocol for cancer biomarkers discovery (Q34449879) (← links)
• Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder (Q34565890) (← links)
• Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine (Q34675774) (← links)
• Recent progress in mouse models for tumor suppressor genes and its implications in human cancer (Q36929407) (← links)
• Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding (Q37108161) (← links)
• Human urine proteomics: building a list of human urine cancer biomarkers. (Q37890422) (← links)
• Overexpression of COPS3 promotes clear cell renal cell carcinoma progression via regulation of Phospho-AKT(Thr308), Cyclin D1 and Caspase-3. (Q52686884) (← links)
• A qualitative proteome investigation of the sediment portion of human urine: Implications in the biomarker discovery process (Q53077601) (← links)
• Clinical significance of RCAS1 as a biomarker of uterine cancer. (Q53611411) (← links)
• Chemical Optimization of Whole-Cell Transfer Hydrogenation Using Carbonic Anhydrase as Host Protein (Q64070140) (← links)
• Carbonic anhydrase IX expression in prostate cancer (Q82355759) (← links)